HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery
Top Cited Papers
Open Access
- 22 July 2019
- journal article
- research article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 22 (S4), e25298
- https://doi.org/10.1002/jia2.25298
Abstract
Introduction Adolescent girls and young women (AGYW) in Africa have high HIV incidence despite scale-up of HIV testing and HIV treatment. Placebo-controlled trials of tenofovir-based pre-exposure prophylaxi (PrEP) in diverse populations demonstrated that PrEP works with close to 100% effectiveness if taken with high, but not perfect, adherence. Divergent efficacy estimates among African AGYW led to demonstration and implementation projects to better understand motivations for HIV prevention, uptake, adherence and persistence to PrEP. To inform PrEP programmes, the design and initial findings from PrEP demonstration projects for AGYW are reviewed. Discussion Early lessons from PrEP implementation projects among young African women include: (1) awareness and demand creation with positive messaging about the benefits of PrEP are critical to motivate AGYW to consider this novel prevention technology and to foster awareness among peers, partners, parents and guardians to support AGYW's effective PrEP use; (2) PrEP initiation is high in projects that are integrating PrEP into youth-friendly clinics, family planning clinics and mobile clinics; (3) young African women at risk are initiating PrEP, based on behavioural characteristics, history of intimate partner violence, depression and 30% prevalence of chlamydia and/or gonorrhoea; (4) provision of youth-friendly PrEP delivery programmes that integrate reproductive health services, including contraception and the diagnosis and treatment of sexually transmitted infections, increase health impact; (5) messages that emphasize the necessity for high adherence while at potential risk of HIV exposure and support strategies that addresses AGYW's adherence challenges are essential; and, (6) a substantial proportion of AGYW do not persist with PrEP, and strategies are needed to help AGYW assess their ongoing need, motivation and challenges with persisting with PrEP. Conclusions PrEP is feasible to implement in integrated reproductive health service delivery models to reach African AGYW. While PrEP demonstration projects indicate that women with behavioural risks and high rates of sexually transmitted diseases are initiating PrEP; effective strategies to support AGYW's adherence and persistence with PrEP are needed. Lessons learned from oral PrEP delivery, a novel first generation HIV prevention product, are relevant to longer-acting and less adherence-dependent strategies which are currently in clinical trials.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1161329)
This publication has 59 references indexed in Scilit:
- Poverty Impedes Cognitive FunctionScience, 2013
- Adolescent cognitive control and reward processing: Implications for risk taking and substance useHormones and Behavior, 2013
- Impact of socio-emotional context, brain development, and pubertal maturation on adolescent risk-takingHormones and Behavior, 2013
- Preexposure Prophylaxis for HIV Infection among African WomenNew England Journal of Medicine, 2012
- ‘It’s not about money, it’s about my health’: determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South AfricaPatient Preference and Adherence, 2012
- Health Behavior in Developing CountriesAnnual Review of Economics, 2011
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Adolescent risk taking, impulsivity, and brain development: Implications for preventionDevelopmental Psychobiology, 2010
- Doing It Now or LaterAmerican Economic Review, 1999
- Golden Eggs and Hyperbolic DiscountingThe Quarterly Journal of Economics, 1997